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ABSTRACT
Monitoring viruses circulating in the human population and the environment is
critical for protecting public and ecosystem health. The goal of this dissertation was to
incorporate a viral metagenomic approach into virus surveillance efforts (both clinical
and water quality control programs) to enhance traditional virus detection methods.
Clinical surveillance programs are designed to identify and monitor etiological
agents that cause disease. However, the ability to identify viruses may be compromised
when novel or unsuspected viruses are causing infection since traditional virus detection
methods target specific known pathogens. Here we describe the successful application of
viral metagenomics in a clinical setting using samples from symptomatic patients
collected through the Enterovirus Surveillance (EVS) program in the Netherlands
(Appendix A). Despite extensive PCR-based testing, the viruses in a small percentage of
these samples (n = 7) remained unidentified for more than 10 years after collection. Viral
metagenomics allowed the identification of viruses in all seven samples within a week
using minimal sequencing, thus rapidly filling the diagnostic gap. The unexplained
samples contained BK polyomavirus, Herpes simplex virus, Newcastle disease virus and
the recently discovered Saffold viruses (SAFV) which dominated the unexplained
samples (n = 4). This study demonstrated that metagenomic analyses can be added as a
routine tool to investigate unidentified viruses in clinical samples in a public-health
setting. In addition, metagenomic data gathered for SAFV was used to complete four
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genotype 3 SAFV (SAFV-3) genomes through primer walking, doubling the number of
SAFV-3 full genomic sequences in public databases.
In addition to monitoring viruses in symptomatic patients, it is also important to
monitor viruses in wastewater (raw and treated) to protect the environment from
biological contamination and prevent further spread of pathogens. To gain a
comprehensive understanding of viruses that endure wastewater treatment, viral
metagenomics was used to survey the total DNA and RNA viral community in reclaimed
water (the reusable end-product of wastewater treatment) (Appendix B). Phages (viruses
that infect bacteria) dominated the DNA viral community while eukaryotic viruses
similar to known plant and insect viruses dominated RNA metagenomic libraries
suggesting that highly stable viruses may be disseminated through this alternative water
supply. A plant virus, the Pepper mild mottle virus (PMMoV), was identified as a
potential indicator of wastewater contamination based on metagenomic data and
quantitative PCR assays (Appendix C). The metagenomic analysis also revealed a wealth
of novel single-stranded DNA (ssDNA) viruses in reclaimed water. Further investigation
of sequences with low-level similarities to known ssDNA viruses led to the completion of
ten novel ssDNA genomes from reclaimed water and marine environments (Appendix
D). Unique genome architectures and phylogenetic analysis suggest that these ssDNA
viruses belong to new viral genera and/or families. To further explore the ecology of the
novel ssDNA viruses, a strategy was developed to take metagenomic analysis to the next
level by combining expression analysis and immunotechnology (Appendix E). This
dissertation made a significant contribution to current microbiological data regarding
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wastewater by uncovering viruses that endure the wastewater treatment and identifying a
new viral bioindicator.
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CHAPTER 1:
INTRODUCTION

1

Background
Virus Surveillance
The detection of pathogenic viruses circulating in the human population is a
fundamental component of public health monitoring schemes to minimize risks
associated with pathogen transmission. In clinical settings it is critical to monitor viral
pathogens for early detection and intervention (1, 2). For this purpose, pathogens are
usually monitored by collecting samples from patients expressing disease symptoms.
However, the emergence of epizootic diseases has necessitated the ecological
surveillance of viral pathogens in order to identify conditions that may lead to human
infection (e.g. (3-5)). Ecological surveillance involves the detection and identification of
epizootic viruses in animal hosts and environmental reservoirs, including vectors
responsible for transmitting the viruses (e.g. (6-8)). Since pathogenic viruses can be shed
in high numbers in human feces (9-12), wastewater is considered an important source of
pathogens to the environment (13, 14). Therefore it is important to monitor viruses in
wastewater (raw and treated) to protect environments exposed to wastewater discharges
from biological contamination and prevent further spread of pathogens. This type of
surveillance is accomplished through water quality control programs. Although
surveillance efforts in both clinical and water quality control programs aim to limit
pathogen dissemination, their overall objective is different and thus the approaches used
for monitoring viruses differ.
Clinical surveillance programs provide vital information for improving disease
management strategies such as vaccine implementation and vector control (e.g. (15-17)).
Therefore it is of utmost importance to identify and monitor etiological agents that cause
2

disease. The detection and identification of viruses in clinical samples relies on a range of
traditional and modern techniques including cell culture, electron microscopy, serology
and molecular assays designed to screen for specific viral species or closely related
viruses (18). The combination of these molecular techniques is often successful but fails
to produce conclusive results when novel viruses or divergent variants of a known viral
family are involved. This may result in a high percentage (up to 50%) of cases with
unidentified etiological agents (19-22). Moreover, new viruses are frequently discovered,
creating the need to constantly update PCR assays (23-26). Microarrays have been
proposed as a more sensitive tool to monitor viruses with high mutability and have been
shown to provide significant advantages over isolation in culture, immunoassays, and
PCR-based methods (27-29). Notably, microarrays can be used to simultaneously test for
multiple species of viruses, offering an opportunity for massively parallel virus
surveillance (30). However, microarrays often fail to detect etiological agents in clinical
samples from patients suspected to have viral infections (28). New approaches are needed
to identify divergent and novel viruses that standard clinical surveillance methods fail to
detect.
In contrast to clinical scenarios, water quality control programs that monitor the
microbiological quality of wastewater are not designed to detect specific pathogens. The
main goal of water quality programs is to limit the dissemination of fecal-associated
pathogens through wastewater discharges into the environment, consequently minimizing
public exposure to these pathogens. Due to the wide variety of possible pathogens and the
large number of samples that must be tested on a frequent basis, current quality control
methods do not test the presence of pathogens directly (31). Instead, standard detection
3

methods focus on detecting indicator organisms that serve as surrogates for pathogenic
organisms (32). It has been shown that bacterial indicators currently used for
microbiological monitoring of wastewater, such as fecal coliforms and Enterococci, are
easily inactivated compared to viruses and often do not correlate with the occurrence of
viral pathogens in wastewater (33-39). These findings have led several scientists to
propose a suite of viral bioindicators, including coliphage, human adenoviruses and
polyomaviruses, as a more sensitive tool to detect viral pathogens (37, 39-41).
Due to the historical dependence on indicator organisms to monitor water quality,
the virological content of wastewater is still largely unknown. Most microbiological and
risk assessment studies regarding wastewater have examined either indicator organisms
or specific human pathogens (42). However, wastewater may also be a reservoir for nonhuman pathogens that are present in human waste. For example, it has been shown that
plant viruses dominate the RNA viral community in human feces (43). Other studies have
identified animal rotavirus strains of unknown origin co-circulating with human strains in
sewage and treated wastewater (44, 45). Furthermore studies investigating the viral
community in stool from South Asian children have identified an abundance of novel
picornaviruses related to animal and insect pathogens (46, 47). Therefore, in addition to
human pathogens, the diverse viral flora in human feces may contain plant, insect, and
animal viruses. Since wastewater is ultimately discharged into the environment, it is
relevant for ecosystem health to evaluate if these non-human pathogens are also present
in wastewater. If current treatments fail to remove plant and insect pathogens from
wastewater this may have implications for the use of treated effluent (i.e. reclaimed
water) for agricultural irrigation. In order to protect public and environmental health,
4

there is a need to assess the total viral community in wastewater instead of focusing
exclusively on human viruses.

Limitations of Current Methods Used for Virus Surveillance
The methods conventionally used for virus surveillance are limited as these
methods heavily depend on a priori knowledge of the viruses that are being targeted. In
clinical settings if novel or unsuspected viruses are causing infection, then current
methods that target a specific virus or group of viruses will fail to identify the etiological
agent. Although water quality control programs aim to detect bioindicators rather than
specific pathogens, the scarce knowledge regarding the viral content in wastewater
demonstrates the need to survey the viral community in wastewater. Information from
these surveys can later be used to identify new and improved viral bioindicators, test the
efficacy of different wastewater treatment techniques, and evaluate potential impacts on
ecosystem health. However, current methods in water quality programs do not allow for
total viral community analyses since no single monitoring assay can target all viruses. In
view of the limitations of methods that target specific viruses, new approaches are
required for the identification of novel or “unsuspected” viruses in surveillance schemes.
One promising approach for viral identification and community analysis is the use of
virus particle purification and metagenomic sequencing (viral metagenomics).

5

Metagenomics for Virus Discovery and Viral Community Analysis
Traditional approaches used to identify viruses in surveillance programs are
problematic because they require prior knowledge of the viruses that are being targeted.
For example, culture-based methods depend on the availability and selection of
appropriate susceptible host cells to propagate viruses. Molecular approaches, such as
PCR assays, require knowledge regarding genomic information for primer design.
Moreover, viruses do not have ubiquitously conserved genetic elements such as
ribosomal DNA that can be used to amplify and identify all viruses (48). Thus, there is no
universal PCR assay that can target all the viruses in a sample. Although microarrays can
be used for massive parallel detection of multiple viral species, the assay still depends on
oligoprobes based on known viruses and, thus, may fail to detect divergent viral species.
Furthermore each microarray will only detect viruses that can bind to the oligoprobes
included in the assay (30). These limitations make traditional methods insufficient for
virus surveillance strategies that need to characterize novel viruses in clinical samples or
investigate the total viral community found in wastewater.
Metagenomic (whole community) analyses offer an opportunity to circumvent
limitations found in current assays used for virus surveillance and directly describe the
composition and structure of uncultured viral communities. In contrast to specific assays
that are designed to recover a single virus or a group of closely related viruses, viral
metagenomics allows the identification of viruses in a sample without a priori knowledge
of the viral types present (49, 50). It is important to distinguish viral metagenomics,
where viruses are purified before shotgun sequencing and yield of viral sequences is high
(51), from a direct metagenomics approach, where total homogenates are sequenced and
6

viruses only account for a small proportion of the sequences (52). Viral metagenomics
has been used to describe viruses in mammalian feces (43, 47, 53-57), cell cultures (46,
58), respiratory tract aspirates (25, 59), blood (58, 60), and animal tissues (61, 62) as well
as to characterize viral communities present in different environments (63-67). Applying
a viral metagenomic approach into virus surveillance efforts will allow the description of
unidentified viruses in clinical samples and characterization of the entire viral community
in wastewater, as opposed to using specific assays for a limited number of viruses. This
novel approach will enhance and complement current methods used for virus
surveillance.

Overall Research Objectives
The overarching goal of this research project was to apply viral metagenomics in
virus surveillance efforts including clinical and water quality control programs. The
project objectives included:
1) Characterization of unidentified viruses in samples collected through an
established clinical surveillance program
2) Description of the complete DNA and RNA viral community in treated
wastewater
3) Identification of a potential new viral bioindicator for water quality assessments
4) Characterization of newly described single-stranded DNA (ssDNA) viruses
identified in wastewater

7

Research Overview
Viral metagenomics was used to enhance current methods for virus surveillance
in clinical and water quality control programs. The information gathered during the
project was used to make recommendations for clinical surveillance programs and add to
the current microbiological data regarding viruses in wastewater. The objectives of the
project were accomplished through the following studies:

Appendix A: Metagenomic Sequencing for Virus Identification in a Public Health
Setting
o This study describes systematic analysis of 1834 clinical specimens
cultured from symptomatic patients as part of the Enterovirus Surveillance
program in the Netherlands through a combination of PCR-based assays
and viral metagenomics. During the investigated 13-year period (19942007), a total of seven samples exhibited reproducible cytopathogenic
effects in cell culture and tested negative for standard PCR assays and,
thus, remained unexplained. In order to fill the diagnostic gap,
metagenomic sequencing was applied to virus particles purified from the
unexplained cell culture samples. Viral metagenomics resulted in the rapid
identification of viruses in all the samples with minimal sequencing. This
study demonstrated that viral metagenomics is a powerful tool that can be
integrated into public health monitoring efforts to investigate unexplained
infections that standard PCR assays fail to detect. In addition, four
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genomes of the recently discovered Saffold virus were completed and
reported as part of this work.
Appendix B: Metagenomic Analysis of Viruses in Reclaimed Water
o The use of reclaimed water (i.e., the reusable end product of wastewater
treatment) is an important component of sustainable water resource
management. The primary goal of this study was to characterize the DNA
and RNA viral community found in reclaimed water in an effort to detect
viruses that endure the wastewater treatment process. The data suggested
that reclaimed water may play a role in the dissemination of highly stable
plant viruses and other novel viruses that have not been previously
described. Stable viruses found in reclaimed water may share the same
resistance to wastewater treatment processes as some pathogens of
concern to public health. Therefore reclaimed water represents an
untapped source for discovering new bioindicators that can serve as
surrogates for pathogen detection in water supplies.

Appendix C: Pepper Mild Mottle Virus as an Indicator of Fecal Pollution
o Accurate indicators of fecal pollution are needed to minimize public health
risks associated with wastewater contamination in recreational waters. A
plant virus, Pepper mild mottle virus (PMMoV), was identified as a
potential novel indicator of wastewater contamination metagenomic
sequencing of reclaimed water. Quantitative PCR assays showed that
PMMoV is widespread and abundant in wastewater throughout the United
9

States, including both raw sewage and treated effluent. Further testing
revealed the presence of PMMoV in seawater samples collected near point
sources of secondary-treated wastewater where it co-occurred with several
human pathogens and other proposed indicators of fecal pollution. The
data collected during this study demonstrated that PMMoV is a promising
indicator of fecal pollution in coastal environments.

Appendix D: Diverse Circovirus-like Genome Architectures Revealed by Environmental
Metagenomics
o One of the biggest advantages of metagenomics is the potential to uncover
new viruses directly from environmental communities without having
prior knowledge of their existence. The reclaimed water DNA viral
metagenome contained a wealth of sequences with low levels of
similarities to single-stranded DNA (ssDNA) viruses. This study focused
on further investigating these sequences through the complete sequencing
of five novel genomes. Data-mining of environmental datasets resulted in
the completion of an additional five genomes with similar characteristics
from metagenomic libraries of three different marine environments
(Chesapeake Bay, British Columbia coastal waters, and Sargasso Sea).
The ten novel genomes shared similarities with ssDNA circoviruses;
however, only half exhibited genomic features consistent with known
circoviruses. Unique genome architectures and phylogenetic analysis
suggest that these viruses belong to new viral genera and/or families. This
10

study revealed an unprecedented diversity of ssDNA viruses with unique
features in the environment.
Appendix E: Method Development for the Characterization of Novel Single-stranded
DNA Viruses
o Metagenomic analyses have led to the discovery of a diversity of unknown
ssDNA viruses in the environment. Since the novel ssDNA viruses have
been identified directly from environmental sequence datasets and the
hosts are unknown we are extremely limited in our ability to characterize
these viruses. This study aimed to take metagenomic analysis to the next
level by combining expression analysis and immunotechnology to
describe novel ssDNA viruses in reclaimed water. Recombinant
expression of structural proteins would allow us to isolate unknown
viruses from environmental samples by virtue of the antigenic properties
of these proteins. For this purpose, the potential structural genes of novel
viruses were identified from assembled genomes based on conserved
genome organizations. However, the expression of the environmental
ssDNA viruses proved to be difficult in the selected bacterial expression
system and future studies should evaluate eukaryotic expression systems.
This research will provide a method for isolation and characterization of
unknown ssDNA viruses in the environment based on structural genes
found in metagenomic libraries.
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CHAPTER 2:
RESEARCH IMPACTS AND CONCLUSIONS
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Research Impacts
Virus surveillance programs are an integral component of public health
monitoring efforts designed to minimize public exposure to pathogens. However,
monitoring efforts are limited in their ability to detect pathogens since current methods
specifically test for a limited number of pathogens, thus relying on prior knowledge of
the targeted viruses. The goal of this project was to incorporate a virus metagenomic
approach into virus surveillance schemes, including clinical and water quality control
programs, to circumvent methodological limitations traditionally associated with virus
detection. Metagenomics enhanced viral surveillance in a clinical setting by enabling the
characterization of infectious viral agents in unidentified clinical specimens. In addition,
sequencing of the viral metagenome from reclaimed water (the reusable end-product of
wastewater treatment) described viruses that endure wastewater treatment, identifying
new viral bioindicators that can be used to improve water quality monitoring and
uncovering viruses that are not commonly thought to be associated with wastewater.

Viral Metagenomics and Clinical Surveillance
The application of viral metagenomics in a clinical setting was tested using
samples collected through the Enterovirus Surveillance (EVS) program in the
Netherlands. In its current form, the EVS program monitors the circulation of
enteroviruses to ensure the eradication of poliovirus from the Netherlands (1, 2).
Although routine virological laboratories across the country perform a range of tests for
enteroviruses, all cell culture samples exhibiting cytopathogenic effects (CPE) that
cannot be identified are submitted to the Center for Infectious Disease Control, National
21

Institute for Public Health and the Environment (RIVM) in the Netherlands for virus
identification and typing by PCR. Between 1994 and 2007, a total of 1742 unidentified
cell culture isolates exhibiting consistent CPE were submitted to RIVM. PCR assays for
enteroviruses and parechoviruses performed at RIVM successfully identified viruses in
approximately 98% of these isolates. The remaining 2% of the samples were subjected to
extensive PCR testing for a wide range of viruses, including noroviruses, rotaviruses A, B
and C, adenoviruses, astroviruses, sapoviruses, vesiviruses, reoviruses, a generic PCR
that detects both enteroviruses and rhinoviruses, hepatitis A and E viruses, influenza A
and B viruses, Aichi virus, coronaviruses 229E, NL63 and OC43, human respiratory
syncytial viruses A and B and human metapneumovirus. In addition, samples that
remained negative had to be retrospectively analyzed every time PCR assays were
updated to include a broader diversity of viruses. The process of successive PCR testing
for each of these viruses was extremely time-consuming and labor-intensive, with
diminishing returns as some of these virus groups were not detected in any of the
samples.
The EVS program needs to identify all viral agents associated with clinical
specimens collected throughout the Netherlands to ensure that infections are not
associated with poliovirus and track enteric viruses circulating in the population.
However, extensive PCR testing failed to identify viruses in seven cell culture samples
that exhibited consistent CPE. Some of the samples from the EVS program remained
unidentified for more than 10 years after collection, despite frequent updates to improve
the PCR assays over time. As presented in this dissertation, viral metagenomics allowed
the identification of viruses in all seven samples within a week using minimal sequencing
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(< 50 clones per sample). The unexplained samples contained BK polyomavirus, Herpes
simplex virus, Newcastle disease virus and the recently discovered Saffold viruses
(SAFV) which dominated the unexplained samples (n = 4). Although all of these viruses
had been previously described, they were not included in assays performed at RIVM
because they were not suspected to cause an infection in the samples collected. This
assumption precluded the identification of viruses in all the samples, keeping the EVS
program from meeting its goal. Metagenomic analysis does not require prior knowledge
of the viruses in a sample for identification and, thus, this approach was successful in
identifying infectious agents in all the samples.
Although viral metagenomics was originally developed to describe total viral
communities in environmental samples (3), this dissertation proved the effectiveness of
viral metagenomics as a strategy for clinical surveillance. Viral metagenomics was a
more efficient and cost-effective alternative than individual PCR assays for different
viruses, other than enteroviruses and parechoviruses, in the EVS program. In addition, the
discovery of genotype 3 SAFV (SAFV-3) in the EVS samples contributed to genomic
data regarding these newly discovered RNA viruses.

Prior to the completion of the

SAFV-3 found in the EVS samples there were only three SAFV-3 genomes in public
databases. The metagenomic data gathered for SAFV was used to complete four SAFV-3
genomes through primer walking, thus doubling the number of SAFV-3 full genomic
sequences in the database. This study demonstrated that metagenomic analyses can be
added as a routine tool to investigate unidentified viruses in cell cultures from clinical
samples in a public-health setting. Therefore, we recommend the use of viral
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metagenomics on cell culture samples that test negative for established PCR assays in
virus surveillance programs.

Viral Metagenomics and Water Quality
Viral metagenomics was used to describe the total DNA and RNA viral
community in reclaimed water. Reclaimed water is an important component of water
reuse programs that aim to reduce the discharge of wastewater effluent into surface
waters and conserve water by supplying water for activities that do not require drinking
water quality standards. However, this means that the public will be exposed to treated
wastewater effluent through the use of reclaimed water for non-potable public water
supply, agricultural irrigation, environmental enhancement and industrial uses. As water
reuse applications increase and reclaimed water distribution expands, there are some
concerns that need to be addressed to ensure protection of public health and the health of
the environment, including the potential for pathogen dissemination through this
alternative water supply. Since the virological content of wastewater is still largely
unknown, viral metagenomics was used to survey the total viral community in an effort
to gain a comprehensive understanding of viruses that endure wastewater treatment. The
information gathered during this study was used to identify potential new bioindicators of
fecal pollution and bring attention to non-human viruses that have been overlooked when
considering water quality.
The DNA viral community in reclaimed water was dominated by phages (viruses
that infect bacteria). After comparing this viral community with a potable water viral
metagenome, reclaimed water had a distinct phage community based on phage family
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distributions and host representation within each family. Therefore, although phages
dominate both conventional and alternative water supplies, the types of phages in each
water supply differ. From a water quality standpoint, it is useful to evaluate which types
of phages endure wastewater treatment processes but are not present in potable water in
order to identify potential viral bioindicators. Finding strong bioindicators that correlate
with the presence of human viruses is not an easy task as different viruses exhibit varying
levels of resistance to wastewater treatment (4). Natural phage populations found in
wastewater offer a range of resistance to disinfection (chlorination) that may represent
most of the viruses that can be found in sewage (5). Therefore, phage populations in
reclaimed water offer an untapped source of potential bioindicators.
Alternatively, eukaryotic viruses, such as plant pathogens, may also be explored
as potential viral bioindicators. Since plant pathogens found in human waste are
suspected to be dietary in origin (6, 7), these viruses may be more abundant in the healthy
human population than viruses that cause human disease. Data from this dissertation
suggest that plant viruses may be good indicators of human fecal pollution. The plant
pathogen Pepper mild mottle virus (PMMoV) was identified as a potential bioindicator
due to its abundance in the reclaimed water RNA libraries and previous findings
indicating that this virus dominates the RNA viral community in human feces (6).
Quantitative PCR assays showed that PMMoV is widespread and abundant (> 104
copies/ml) in wastewater (both raw and treated) across the United States. In addition,
PMMoV was detected in seawater samples collected near point sources of secondary
treated wastewater, where it co-occurred with several other pathogens and indicators of
fecal pollution. PMMoV was not found in non-polluted seawater samples and could be
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detected in surface seawater for approximately 1 week after its initial introduction,
indicating that the presence of PMMoV in the marine environment reflects a recent
contamination event. These findings suggest PMMoV is a promising indicator of fecal
pollution in marine environments. However, the abundance of PMMoV in both raw
sewage and treated wastewater demonstrated that this viral indicator cannot be used to
distinguish between these two sources of wastewater. Instead, PMMoV serves as a
conservative viral tracer of fecal pollution that can be used to represent microconstituents
and pathogens that may not be removed effectively through wastewater treatment
processes. The extremely high concentrations of PMMoV detected in human sewage (up
to 107 copies/ml) compared to the concentration of any human pathogen reported to date
(< 105 copies/ml) (8-11) suggest that this virus would be a good indicator of human fecal
pollution. As a plant pathogen, PMMoV is different from other proposed viral indicators
of fecal contamination since its presence in sewage is dietary in origin and is not
dependent on active human infection.
In addition to potential bioindicators, the reclaimed water metagenome uncovered
a wealth of novel eukaryotic viruses related to viruses that are not commonly associated
with wastewater. Notably, DNA metagenomic libraries revealed the presence of viruses
similar to single-stranded DNA (ssDNA) animal viruses from the Circoviridae family,
which are known avian and porcine pathogens. Further investigation of sequences related
to circoviruses resulted in the completion of five novel circovirus-like genomes. The
unprecedented abundance of these viral sequences in reclaimed water prompted a search
for related viruses in other environmental samples. Data-mining of environmental
datasets resulted in the completion of an additional five circovirus-like genomes from
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metagenomic libraries of three different marine environments (Chesapeake Bay, British
Columbia coastal waters, and Sargasso Sea). The ten novel genomes shared similarities
with ssDNA circoviruses; however, only half exhibited genomic features consistent with
known circoviruses. Some of the genomes exhibited a mixture of genomic features
associated with different families of ssDNA viruses (i.e. circoviruses, geminiviruses and
parvoviruses).

The

abundance

of

circovirus-like

sequences

in

environmental

metagenomic studies and the presence of unique genome sequences and architectures
suggest that there is a complex and largely unexplored community of ssDNA viruses in
the environment.
The identification of circovirus-like sequences in reclaimed water led to the
discovery of novel circovirus genomes in wastewater and the marine environment for the
first time. However, we are extremely limited in our ability to further characterize these
novel viruses since they were identified directly from metagenomic data and the hosts are
unknown. Isolation of novel ssDNA viral particles from the environment will allow
further biological and physicochemical characterization of these unknown viruses. This
task may be possible through recombinant expression of viral structural proteins and
development of immunoassays, such as immunoprecipitation, to isolate native viruses
from environmental samples by virtue of the antigenic properties of these proteins.
However, in this dissertation, efforts to express and purify recombinant circovirus
proteins in a bacterial system were unsuccessful. Refinement of recombinant expression
strategies, such as using a eukaryotic expression system, will allow expression of
divergent structural proteins and future isolation of unknown viruses from the
environment. The combination of metagenomic sequencing, protein expression, and
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immunotechnology is a promising strategy that will help overcome the biggest current
limitation in metagenomic analyses, namely, the connection between new genes, viral
particles, and biological properties.
Other than data on specific human pathogens, information regarding viruses in
wastewater is extremely sparse. Since pathogen transport through wastewater is an
important concern for public and environmental health, there was a need to survey the
total viral community in wastewater to identify viral types that endure wastewater
treatment. The metagenomic analysis of viruses in reclaimed water performed in this
dissertation significantly contributed to current microbiological data regarding treated
wastewater. The genetic information gathered during this study can be used to design
molecular assays to detect viral types of interest and assess their abundance in wastewater
and ecosystems exposed to wastewater discharge. The diversity of both phages and
eukaryotic viruses suspected to be dietary in origin, such as PMMoV, may be examined
to find new and improved viral bioindicators of fecal pollution. Since reclaimed water
contained a wealth of novel single-stranded DNA and RNA viruses related to plant,
animal and insect viruses, this alternative water supply may play a role in the
dissemination of highly stable viruses. Future research needs to evaluate the host range,
infectivity and ecological impacts of novel viruses identified in reclaimed water to ensure
the appropriate use of this important alternative water supply.
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Appendix E
Introduction
Metagenomic analyses of environmental samples have led to the discovery of a
diversity of novel single-stranded DNA (ssDNA) circoviruses in reclaimed water, marine
habitats, lake water, and soil indicating that these viruses are more widespread than
previously recognized (1-3). Generic PCR assays have also revealed a wealth of novel
circoviruses in sewage and stool from humans and animals in different continents
including Africa, South Asia, and North America (4, 5). However, nothing is known
about the ecology of these novel ssDNA viruses. Further characterization of the novel
ssDNA viruses is extremely difficult since these viruses have been identified directly
from environmental metagenomes and their hosts are unknown. Therefore there is a need
to develop strategies to bridge genomic data gathered from metagenomic datasets to
actual biological properties of novel viruses. We propose that the isolation of novel
ssDNA viral particles from the environment will allow further biological and
physicochemical characterization of these unknown viruses. Isolation of novel viruses
may be possible through recombinant expression of divergent structural proteins and
development of immunoassays, such as immunoprecipitation, to isolate native viruses
from environmental samples by virtue of the antigenic properties of structural proteins.
Here we describe efforts to express a putative structural protein from a novel ssDNA
circovirus identified in reclaimed water.
The environmental ssDNA virus chosen for this study has characteristics similar
to members of the Circovirus genus within the Circoviridae family. Known circoviruses
include pathogens of agricultural and veterinary concern as they can cause fatal diseases
in swine and birds (6). However, to date it has not been possible to culture most

Appendix E (Continued)
circoviruses, with the exception of porcine circoviruses, making their study difficult. The
lack of current culturing techniques for most circoviruses is a big limitation and, thus,
many studies have taken advantage of recombinant expression technologies in hopes of
better understanding virus life cycles and developing subunit vaccines for avian and
porcine circoviruses (7-15). Furthermore, recombinantly expressed circovirus capsid
(Cap) proteins sometimes spontaneously self-assemble into virus-like particles (VLPs)
that are morphologically similar to wild type circoviruses and have immunogenic activity
(8, 9, 13). These studies have established the immunogenicity of recombinant circovirus
structural proteins. Therefore successful expression of the cap gene of environmental
circovirus genomes may allow us to design immunological assays to detect and select for
these viruses in the environment.

Methods
Plasmid Construction
The coding sequence of an unknown open reading frame (ORF) suspected to
encode the capsid protein (designated UCap for unknown capsid) of the RW-A circovirus
(Genbank accession no. FJ959077) was used for recombinant expression. Total viral
DNA used to produce the reclaimed water metagenome was used to amplify the entire
ucap ORF from RW-A using PCR (see Table 1 for primers). The PCR product was
ligated into the pETBlue-1 vector (Novagen, Gibbstown, New Jersey). This pETBlueUCap plasmid was digested with BglII and EcoRI to excise the ucap ORF, which was
then ligated directionally into the pGEX-6P-2 vector (GE Healthcare, Piscataway, New
Jersey). This vector is designed to express proteins fused to glutathione S-transferase
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(GST) which is advantageous for affinity purification of recombinant proteins. In
addition to full length UCap , several truncated versions of this ORF were expressed.
PCR primers containing SfiI sites were designed to obtain these UCap truncated versions
from the pETBlue1-UCap vector (see Table 1 for primers). Truncated UCap versions
were also ligated directionally into the pGEX-6P-2 vector. All pGEX-UCap constructs
were propagated in Escherichia coli DH10ß cells and plasmids were purified from cells
using the QIAprep Spin Miniprep Kit (Qiagen, Valencia, California). The final plasmids
were sequenced to confirm the GST-UCap fusion and proper phasing.

Protein Expression and Purification
The pGEX-UCap plasmids were expressed in E. coli Tuner cells (Novagen,
Gibbstown, New Jersey). Briefly, transformed cells carrying the recombinant plasmid
were grown to a desired optical density in LB medium containing carbenicillin (50
μg/ml), chloramphenicol (34 μg/ml), and glucose (1%) at 37ᴼC. The expression of
recombinant

protein

in

Tuner

cells

was

induced

by

adding

isopropyl-β-

thiogalactopyranoside (IPTG) and incubating at 37ᴼC. To optimize the expression and
cell culture conditions a range of incubation temperatures (25ᴼC, 30ᴼC, and 37ᴼC), IPTG
concentrations (0, 0.25, 0.50, 1, and 2 mM) and incubation times (3 – 5 hrs) were tested.
Cells were centrifuged at 1,500 xg for 5 min after induction to retrieve expressed
proteins. The pelleted cells were lysed chemically by resuspending the cells in a mixture
of 1X BugBuster Protein Extraction Reagent (Novagen, Gibbstown, New Jersey) (50
μl/ml of culture), Protease Inhibitor Cocktail III- EDTA-free (Calbiochem, Gibbstown,
New Jersey) (5 μl/ml resuspended cells), and Lysonase Bioprocessing Reagent (Novagen,
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Gibbstown, New Jersey) (3 μl/ml resuspended cells) followed by 30 min incubation at
room temperature. The lysates were centrifuged at 10,200 xg for 10 min at 4ᴼC to
separate soluble and insoluble protein fractions. Recombinant proteins in the soluble
fraction were purified using a 50% slurry of Glutathione Sepharose 4B (GE Healthcare,
Piscataway, New Jersey) following the manufacturer’s instructions for batch purification.
All slurry washes were performed with a phosphate-buffered saline (PBS) solution
containing 0.1% Tween. Once the recombinant protein was purified, the GST tag fused to
the ucap ORF was removed by cleaving with the PreScission ProteaseTM (GE Healthcare,
Piscataway, New Jersey). Expression and purification of recombinant GST-UCap were
verified by SDS-PAGE and western blot using an anti-GST antibody.

Nuclear Localization Signal
A possible nuclear localization signal (NLS) sequence was identified on the UCap
of RW-A. To test if this ORF is involved in nuclear localization, human embryonic
kidney cells (293T cells) were transfected with a pcDNA3 vector (Invitrogen) containing
the putative cap gene. The plasmid was constructed by amplifying the UCap ORF from
the pETBlue-UCap vector through PCR using primers containing SfiI restriction sites
(Sense 5’GTGGCCATTAAGGCCACCATGGGAAAGTACACAAAGCGA3’; Antisense5’GTGG
CCACCGCGGCCTAAACCCTGTGCTTCC3’).

The PCR products were digested with Sfi I and

ligated directionally into the pcDNA3 vector. This pcDNA3-UCap plasmid allowed the
expression of the putative Cap fused to an Avi-tag (biotin-acceptor peptide tag) at the Cterminus. The plasmid was propagated in E. coli DH10ß cells and plasmids were purified
from cells using a commercial kit. The final plasmid was sequenced to confirm the ucap
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insert and proper phasing. Human 293T cells were transfected using Lipofectamine 2000
(Invitrogen, Carlsbad, California) and incubated at 37ᴼC for 72 hrs.
In order to evaluate where the expressed UCap-Avi tag localized, the cytosol and
nuclei of harvested cells were lysed separately. To separate nuclei from cytosol, cells
were centrifuged at 500 xg for 1 min. The pelleted cells were resuspended with PBS
containing 0.1% Triton X and the resuspension was then centrifuged at 10,200 xg for 10
min to pellet nuclei. The supernatant (cytosol fraction) was collected and the pelleted
nuclei were resuspended with dithiothreitol (50 mM) and incubated at 100ᴼC for 10 min.
Expression and localization of the UCap-Avi tag fused protein was verified by western
blotting and immunofluorescent assays based on anti-Avi monoclonal antibodies. Human
293T cells expressing the green fluorescent protein (GFP) were used as a control.

Results and Discussion
This study explored a method for the recombinant expression of an unknown gene
suspected to encode the structural protein of the novel ssDNA virus RW-A. The RW-A
circovirus was identified from a reclaimed water viral metagenome (1, 16). The RW-A
genome was confirmed by PCR and the virus was detected in raw sewage and treated
effluent samples collected in two different years (2007 and 2009) suggesting that the
virus is consistently present in wastewater. RW-A genomic features are consistent with
known circoviruses including a small genome (2,162 nt) that encodes two major open
reading frames (ORFs) in an ambisense organization and a conserved nonanucleotide
motif located at the apex of a potential stem-loop structure (Fig. 1). However, RW-A
only shares 36% amino acid identity within the replication-associated (Rep) protein of an
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avian circovirus and there are no matches in the database for the second ORF. We
hypothesized that the unknown ORF (i.e. ucap) encodes for the Cap protein due to its
orientation with respect to the rep, size, and N-terminus amino acid composition.
The goal of this study was to obtain a purified recombinant protein that could be
used to develop immunoassays to detect and isolate RW-A from environmental samples
in the future. For this purpose, the RW-A UCap ORF was expressed using a bacterial
expression system. The E. coli system was chosen because bacterial expression
techniques are relatively simple and produce results in a short amount of time. The
biggest concerns with this system are related to the possible outcomes of expressing
eukaryotic proteins in a prokaryotic cell environment. It is possible that expressed
proteins are not properly modified and expression of insoluble proteins or overproduction
may result in the precipitation of the foreign protein into inclusion bodies. Nevertheless
various studies have successfully expressed recombinant circovirus proteins in E. coli and
retained their antigenic properties causing an immune response and reacting with
antibodies for wild type viruses (10, 12, 14, 17).
Unfortunately, efforts to express and purify the RW-A UCap protein using a
bacterial system were unsuccessful in this study. Although the GST-UCap fused protein
was expressed in Tuner cells, low protein yields were obtained and degradation products
were more concentrated than full length products. This outcome may be due to an
arginine-rich region at the N-terminus of the predicted UCap amino acid sequence. This
is characteristic of known circoviruses which contain a region high in basic residues at
the N-terminus of the Cap, most notably arginine (6, 18). It has been confirmed that this
sequence high in basic amino acids interferes with the cap gene expression in E. coli
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resulting in low yields (12, 14) probably because of rare codon usage in E. coli (17). A
few studies have successfully expressed the Cap protein by removing the arginine-rich
region from the amino acid sequence (10, 14). Another recent strategy was to use an
engineered E. coli strain that contains extra copies of genes that encode rare tRNAs (17).
However, the expression of truncated versions of the GST-UCap and the use of an E. coli
strain (Rossetta-gamiTM) with extra copies of rare tRNAs were also unsuccessful in this
study. Truncated products were expressed, but precipitated into inclusion bodies and
could not be purified.
The E .coli system was chosen due to its simplicity compared to other expression
systems. Since the recombinant expression of RW-A UCap in E. coli resulted in typical
problems encountered when expressing eukaryotic proteins in a prokaryotic environment,
we suggest future studies express this protein in an eukaryotic expression system such as
baculovirus. The baculovirus expression system is the most widely used expression
system for the preparation of VLPs (19). In this system the gene of interest is inserted
into an insect virus (vector) and the desired foreign protein is produced by growing the
recombinant virus in cultured insect cells. This system has many advantages for the
expression of eukaryotic viral proteins, most notably the expressed proteins are usually
properly folded and transported to the proper cellular compartment (i.e. membrane
proteins are localized to the insect cell membrane, nuclear proteins to the nucleus, and
secreted proteins are secreted into the medium) (19).
The arginine-rich amino acid sequence at the N-terminus of circoviurs Cap
proteins is believed to be a nuclear localization signal (NLS) involved in viral DNA
translocation across the host nucleus (7, 15, 20). This potential NLS was identified at the

Appendix E (Continued)
N-terminus of RW-A UCap ORF and, thus, we hypothesized this protein localizes to the
nucleus. In order to test this hypothesis, the RW-A UCap ORF was expressed in human
293T cells. Transfected 293T cells successfully expressed the recombinant protein.
Western blotting (Fig. 1) and immunofluorescent assays (Fig. 2) suggest that the putative
Cap protein does localize to the nucleus. The karyophilic nature of the capsid protein has
been shown for both porcine and avian circoviruses (7, 15, 20). The concentration of the
RW-A UCap in the nucleus further supports that this unknown ORF encodes a capsid
protein.
It is important to obtain recombinant structural proteins in order to develop
strategies to study novel ssDNA viruses. In general, the combination of metagenomic
sequencing, protein expression, and immunotechnology will allow us to make a
connection between genes and viral particles. Purified capsid proteins and/or VLPs can
be used to obtain polyclonal antibodies that could be used to isolate wild-type viruses
from the environment. Immunomagnetic separation assays can then be developed to
concentrate and isolate wild-type viruses corresponding to the sequences of interest. Once
wild-type viruses are isolated we can study the physicochemical properties of the
particles, such as morphology and virion stability. This information will be beneficial for
taxonomic classification since the International Committee on Taxonomy of Viruses
requires visualization of the viral particles in order to classify novel viruses (21). In
addition, the isolation of viral particles will allow us to correctly annotate structural
proteins expanding our knowledge regarding viral capsid proteins. This information will
contribute correctly annotated viral sequences to the database, which will in turn allow
for the identification of more divergent structural genes in the future. Finally, one of the
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biggest challenges in viral metagenomics is finding potential hosts for unknown viral
sequences. Immunoassays can also be used to determine potential hosts of unknown
viruses. Western blot assays can be developed to screen a panel of sera from potential
hosts including humans and animals. These Western blot assays can allow us to
determine whether a reaction will occur between the sera and the recombinant protein (a
positive reaction suggests that the host has been exposed to the protein in the past). In
addition, if immunomagnetic separation assays are successful, it will be possible to
perform infectivity studies with novel viruses on different hosts. All these efforts will add
valuable information regarding unknown ssDNA viruses, which is critical as these
viruses continue to be discovered through environmental metagenomics.

Appendix E (Continued)
Table 1. Primers used to obtain the full length coding region for the RW-A unknown
protein (UCap) and truncated versions of the protein
Primer Pair (5’ – 3’)
UCap product
Sense: TTTGCATATGGAATGGGAAA
Antisense: CAATCATAAACCCTGTGCTTCC
Sense: GTGGCCATTATGGCCCCGCAAAGAATCCCTTC
Antisense: GTGGCCACCGCGGCCTCATAAACCCTGTGCTTCC
Sense: GTGGCCATTATGGCCCCGCAAAGAATCCCTTC
Antisense: GTGGCCACCGCGGCCTCAAAACTCCCCGCTTCCGGT
Sense: GTGGCCATTATGGCCCAAGCCTTGCATGGATC
Antisense: GTGGCCACCGCGGCCTCATAAACCCTGTGCTTCC

Full length
No arginine-rich region
at N-terminus
N-terminus half of the
protein (excluding
arginine-rich region)
C-terminus half of the
protein
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1758 nt

Poly-A signal

RW - A
2162 nt

Poly-A signal

2035 nt

Poly-A signal

Figure 1. Schematic genome organization of known circoviruses (left) and the novel
RW-A circovirus (right) showing major open reading frames (ORFs) and a potential
stem-loop structure (green feature). RW-A contains two major ORFs, the replicationassociated (rep) gene (36% amino acid level identity to known Rep proteins from
circoviruses) and an unknown ORF (no significant homologs in the database). This
genome organization is consistent with known circovirus genomes including swine (e.g.
Porcine circovirus, NC001792) and bird (e.g. Gull circovirus, NC008521) pathogens. The
unknown ORF is believed to encode for the capsid protein due to its orientation with
respect to the rep ORF, size, and N-terminus amino acid composition.
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GFP

Capsid

Figure 2. Western blot autoradiograph of 293T cells expressing the green fluorescent
protein (GFP) and the putative capsid protein from the circovirus RW-A. The nuclear and
cytosol fractions were separated. GFP (lanes G) is a cytoplasmic protein while the
putative capsid (lanes CP) is expected to localize to the nucleus due to a nuclear
localization signal at the N-terminus. The GFP signal is concentrated in the cytosol
fraction (left) while the putative capsid protein is concentrated in the nuclear fraction
(right), confirming that this protein localizes to the nucleus.

Dark field
(fluorescence)

Light field

Figure 3. Immunofluorescence microscopy of 293T cells expressing the putative capsid
protein from circovirus RW-A. The signal of the expressed capsid protein is concentrated
in the nucleus of the cells suggesting the capsid proteins localize to the nucleus.
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